clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00136526 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
P4135 | maximum age | 83 | |
P2899 | minimum age | 21 | |
P1132 | number of participants | 30 | |
P859 | sponsor | University of Washington | Q219563 |
P580 | start time | 2002-12-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer: A Phase II Study |
Search more.